![Partnership to Promote Multi-Ancestry PRS Breast Cancer Testing](https://www.g2intelligence.com/wp-content/uploads/2023/02/March23.LIR_.DXDeals-iStock-1800x1250-1-1080x675.jpg)
Partnership to Promote Multi-Ancestry PRS Breast Cancer Testing
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.